Shares of Monsanto Co. (NYSE:MON) have been assigned a consensus rating of “Buy” from the twenty-six ratings firms that are covering the stock. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $112.85.
A number of analysts have issued reports on MON shares. TheStreet downgraded Monsanto from a “buy” rating to a “hold” rating in a research note on Monday, September 12th. Citigroup Inc. raised their target price on Monsanto from $112.00 to $116.00 and gave the stock a “neutral” rating in a research note on Friday, August 19th. Monness Crespi & Hardt cut their target price on Monsanto from $130.00 to $128.00 and set a “buy” rating for the company in a research note on Monday, October 3rd. JPMorgan Chase & Co. set a $128.00 target price on Monsanto and gave the stock a “buy” rating in a research note on Thursday. Finally, BMO Capital Markets set a $128.00 target price on Monsanto and gave the stock a “buy” rating in a research note on Thursday, September 15th.
Monsanto (NYSE:MON) opened at 103.36 on Wednesday. The company has a 50 day moving average of $104.86 and a 200 day moving average of $101.43. The company has a market capitalization of $45.24 billion, a price-to-earnings ratio of 34.59 and a beta of 1.19. Monsanto has a 52 week low of $83.73 and a 52 week high of $114.26.
Monsanto (NYSE:MON) last posted its quarterly earnings data on Wednesday, October 5th. The company reported $0.07 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The firm earned $2.56 billion during the quarter, compared to the consensus estimate of $2.38 billion. During the same period in the prior year, the company earned ($0.19) EPS. The firm’s revenue was up 8.8% compared to the same quarter last year. On average, equities analysts forecast that Monsanto will post $4.89 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be given a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a yield of 2.09%. The ex-dividend date of this dividend is Wednesday, October 5th. Monsanto’s dividend payout ratio (DPR) is 71.05%.
In other Monsanto news, CEO Michael K. Stern sold 12,797 shares of Monsanto stock in a transaction that occurred on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the transaction, the chief executive officer now owns 21,583 shares of the company’s stock, valued at $2,196,501.91. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, COO Brett D. Begemann sold 27,980 shares of Monsanto stock in a transaction that occurred on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total value of $2,899,287.60. Following the transaction, the chief operating officer now directly owns 102,480 shares in the company, valued at approximately $10,618,977.60. The disclosure for this sale can be found here. Company insiders own 0.88% of the company’s stock.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. WFG Advisors LP raised its position in Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock valued at $104,000 after buying an additional 158 shares during the period. Signaturefd LLC raised its position in Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock worth $112,000 after buying an additional 415 shares during the last quarter. Mycio Wealth Partners LLC raised its position in Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock worth $113,000 after buying an additional 12 shares during the last quarter. Pinkerton Retirement Specialists LLC raised its position in Monsanto by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock worth $114,000 after buying an additional 1,014 shares during the last quarter. Finally, Howard Hughes Medical Institute bought a new position in Monsanto during the first quarter worth about $110,000. 79.02% of the stock is currently owned by institutional investors.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.